Exercise tolerance in cystic fibrosis patients treated with elexacaftor/tezacaftor/ivacaftor

Effects of CFTR modulator therapy in cystic fibrosis

Chair(s): Stojka Fustik, Mirjam Stahl

Session type: Poster session

Ivan Bambir

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy (ETI) for one-year and changes in chronic rhinosinusitis in people with cystic fibrosis (pwCF)

Shahid Sheikh

Poster

Abstract

Nutritional status of cystic fibrosis patients under CFTR modulators therapy - a 6 months experience

Mihaela Dediu

Poster

Abstract

Late Breaking Abstract - Infertility among adults with primary ciliary dyskinesia

Leonie Daria Schreck

Poster

Abstract

CFTR-modulator therapy effect assessed by CT and MBW in infants and toddlers with CF

Rikke Sandvik

Poster

Abstract

The long-term respiratory effect of Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis

Mohamad Hadhud

Poster

Abstract

Improved bone mineral density following highly effective CFTR modulator treatment in children and young adults with cystic fibrosis

Aleksandra Zver

Poster

Abstract

Description of the variations in airway colonization in patients with cystic fibrosis in treatment with the combination of Ivacaftor, Tezacaftor and Elexacaftor (ITE)

Jonathan Benito Paton

Poster

Abstract

Impact of elexacaftor/tezacaftor/ivacaftor on chronic rhinosinusitis in children with cystic fibrosis.

Beatrice Della Gatta

Poster

Abstract

Possible founder effect and prevalence of the p.Cys1400Ter pathogenic CFTR mutation in Cyprus

Pinelopi Anagnostopoulou

Poster

Abstract

Impact of Kaftrio on exercise capacity in children with Cystic Fibrosis

Molla Imaduddin Ahmed

Poster

Abstract

Fraction of exhaled nitric oxide increases in children treated with elexacaftor-tezacaftor-ivacaftor

Isaac Martin

Poster

Abstract

CFTR modulators modify exhaled breath of children with cystic fibrosis within a week.

Emmanuelle Bardin

Poster

Abstract

Exercise tolerance in cystic fibrosis patients treated with elexacaftor/tezacaftor/ivacaftor

Ivan Bambir

Poster

Abstract

Correlations between in-vitro and clinical drug response to CFTR modulators

Felix Ratjen

Poster

Abstract

Modulatory therapy experience in patients with cystic fibrosis in Turkey: A multi-center study

Yasemin Gokdemir

Poster

Abstract

Evaluation of the impact of cystic fibrosis modifier therapies on liver function in children and young adults

Sophie Hodgson

Poster

Abstract

Cystic fibrosis fransmembrane regulator modulator therapies effect on liver function in Bulgarian patients

Dilyana Petkova

Poster

Abstract

Late Breaking Abstract - Epidemiology, clinical features and disease severity in pediatric patients with COVID-19 in maternal and children's central hospital in Batumi, Georgia

Tamar Bakhtadze

Poster

Abstract

The ERS International Congress 2023, Milan

#{title}